Evidence against the current hypothesis of 'Gene dosage effects' of trisomy 21: ets-2, encoded on chromosome 21' is not overexpressed in hearts of patients with Down Syndrome

Biochemical and Biophysical Research Communications

Volumn 254, Issue 2, 1999, Pages 395-399

  Greber Platzer, Susanne ^a   Schatzmann Turhani, Dritan ^a   Wollenek, Gregor ^a   Lubec, Gert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Down syndrome; ets 2; Heart malformation; Protooncogene

Indexed keywords

BETA ACTIN; MESSENGER RNA;

ARTICLE; CHROMOSOME 21; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; GENE DOSAGE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HEART MUSCLE BIOPSY; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; INFANT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRISOMY 21;

EID: 0033582256     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1998.9743     Document Type: Article

References (9)

1. Korenberg J. R., Kurnit D. M. Molecular and stochiastic basis of congenital heart disease in Down Syndrome. Developmental Mechanisms of Heart Disease. 1995;Futura Publishing Co, Inc. Armonk. p. 581-596.
2. Kola I., Christiano F., de Haan J. B., Thomas R., Sumarsono S., Corrick C. M., Tymms M. Genes, embryogenesis and Down Syndrome. Moeloek F. A., Affandi B., Trounson A. O. Advances in Human Reproduction. 1995;309-320.
3. Personett D. A., Chouinard M., Sugaya K., McKinney M. Simplified RT/PCR quantitation of gene transcripts in cultured neuroblastoma (SN 49) and microglial (BV-2) cells using capillary electrophoresis and laser-induced fluorescence detection. Electrophoresis. 17:1996;512-517.
4. Schatzmann-Turhani, D. Greber-Platzer, S. Cairns, N. Lubec, G. Determination of the protooncogene ets-2 gene transcript in human brain at the attogram level by the use of competitive RT-PCR, Amino Acids.
5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid gunidinium thiocyanate-phenol-chloroform extraction. Analyt Biochem. 162:1987;156-159.
6. Rychlik W., Rhoads R. E. A computer program for choosing optimal oligonucleotide primers for filter hybridization, sequencing and in vitro amplification. Nucleic Acids Res. 17:1989;8543-8551.
7. Patterson. The causes of Down Syndrome. Sci Am. 257:1987;42-43.
8. Epstein C. J., Korenberg J. R., Anneren G., Antonarakis S. E., Ayme S., Courchesne E., Epstein L. B., Fowler A., Groner Y., Huret J. L., Kempter T. L., Lott I. T., Lubin B. H., Magenis E., Opitz J. M., Patterson D., Priest J. H., Pueschel S. M., Rapoport S. I., Sinet P. M., Tanzi R. E., de la Cruz F. Protocols to establish genotype-phenotype correlations in Down Syndrome. Am J Human Genet. 49:1991;207-235.
9. Shapiro B. L. Whither Down Syndrome critical regions. Hum Genet. 99:1997;421-423.